WEBSITE BSE:541167 NSE: YASHO Inc. Year: 1985 Industry: Chemicals
Last updated: 15:45
Yasho Industries Ltd manufactures and supplies speciality chemicals, meals antioxidants, aroma chemical compounds, rubber accelerators, and lubricant components in Europe, America, the Middle East, and Asia. The company offers various chemicals, including fatty esters and herbal essential/aroma oils, which serve personal care, cosmetics and toiletries, flavours and fragrances, and pharmaceutical industries; and food antioxidant chemical substances, which include tertiary-butyl hydroquinone, butylated hydroxy anisole, ascorbyl palmitate, and dif...Read More
Yasho Industries Ltd manufactures and supplies speciality chemicals, meals antioxidants, aroma chemical compounds, rubber accelerators, and lubricant components in Europe, America, the Middle East, and Asia. The company offers various chemicals, including fatty esters and herbal essential/aroma oils, which serve personal care, cosmetics and toiletries, flavours and fragrances, and pharmaceutical industries; and food antioxidant chemical substances, which include tertiary-butyl hydroquinone, butylated hydroxy anisole, ascorbyl palmitate, and different antioxidants which might be used in diverse food merchandise containing oils and fat. It additionally offers lube and rubber range chemical substances, which include aminic antioxidants, molybdenum based additives, and corrosion inhibitors for petroleum and artificial lubricant industries. In addition, the enterprise provides chemicals to be used in industries, consisting of electroplating chemical compounds, intermediates for API/bulk tablets, UPR resins/fiber composites resins, thermoplastics urethanes, and printing inks and agrochemicals. The company was founded in 1985 and is based in Mumbai, India. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹1672 Cr.
Stock P/E 273.9
P/B 3.9
Current Price ₹1387
Book Value ₹ 354.6
Face Value 10
52W High ₹2232.6
Dividend Yield 0.04%
52W Low ₹ 1151
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 150 | 141 | 130 | 172 | 174 | 167 | 149 | 183 | 199 | 183 |
| Other Income | 1 | 2 | 3 | 0 | 0 | 0 | 1 | 3 | 0 | 0 |
| Total Income | 152 | 143 | 133 | 172 | 175 | 167 | 150 | 186 | 199 | 184 |
| Total Expenditure | 125 | 120 | 108 | 141 | 151 | 136 | 122 | 150 | 165 | 150 |
| Operating Profit | 27 | 23 | 26 | 31 | 24 | 32 | 28 | 36 | 34 | 33 |
| Interest | 3 | 4 | 4 | 4 | 14 | 15 | 16 | 15 | 15 | 14 |
| Depreciation | 4 | 4 | 4 | 4 | 12 | 12 | 13 | 13 | 13 | 13 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 20 | 15 | 18 | 23 | -2 | 5 | -2 | 8 | 6 | 6 |
| Provision for Tax | 5 | 4 | 5 | 5 | 0 | 1 | -1 | 3 | 2 | 1 |
| Profit After Tax | 15 | 12 | 14 | 18 | -2 | 4 | -1 | 5 | 4 | 5 |
| Adjustments | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | -0 |
| Profit After Adjustments | 15 | 12 | 14 | 18 | -2 | 4 | -1 | 5 | 4 | 5 |
| Adjusted Earnings Per Share | 13 | 10.2 | 11.9 | 15.7 | -2.2 | 3.8 | -0.7 | 4.2 | 3 | 4 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Net Sales | 359 | 613 | 672 | 594 | 668 | 714 |
| Other Income | 10 | 10 | 11 | 7 | 9 | 4 |
| Total Income | 370 | 623 | 683 | 601 | 677 | 719 |
| Total Expenditure | 310 | 520 | 557 | 494 | 559 | 587 |
| Operating Profit | 59 | 103 | 126 | 107 | 118 | 131 |
| Interest | 16 | 14 | 16 | 15 | 59 | 60 |
| Depreciation | 12 | 19 | 20 | 16 | 50 | 52 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 31 | 71 | 91 | 77 | 9 | 18 |
| Provision for Tax | 9 | 19 | 23 | 19 | 3 | 5 |
| Profit After Tax | 21 | 52 | 68 | 58 | 6 | 13 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 21 | 52 | 68 | 58 | 6 | 13 |
| Adjusted Earnings Per Share | 19.7 | 45.9 | 59.5 | 50.8 | 5.1 | 10.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 12% | 3% | 0% | 0% |
| Operating Profit CAGR | 10% | 5% | 0% | 0% |
| PAT CAGR | -90% | -51% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -39% | -1% | 44% | NA% |
| ROE Average | 2% | 19% | 25% | 25% |
| ROCE Average | 7% | 15% | 18% | 18% |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Shareholder's Funds | 79 | 173 | 238 | 295 | 420 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 53 | 64 | 157 | 334 | 324 |
| Other Non-Current Liabilities | 14 | 11 | 36 | 83 | 28 |
| Total Current Liabilities | 159 | 235 | 242 | 300 | 322 |
| Total Liabilities | 305 | 483 | 673 | 1012 | 1094 |
| Fixed Assets | 120 | 161 | 177 | 203 | 624 |
| Other Non-Current Assets | 8 | 18 | 161 | 487 | 21 |
| Total Current Assets | 177 | 304 | 335 | 321 | 449 |
| Total Assets | 305 | 483 | 673 | 1012 | 1094 |
| #(Fig in Cr.) | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 1 | 0 | 1 | 0 |
| Cash Flow from Operating Activities | 35 | 16 | 13 | 90 | -42 |
| Cash Flow from Investing Activities | -14 | -59 | -132 | -304 | -9 |
| Cash Flow from Financing Activities | -21 | 43 | 122 | 214 | 59 |
| Net Cash Inflow / Outflow | 0 | -0 | 3 | -0 | 8 |
| Closing Cash & Cash Equivalent | 1 | 0 | 1 | 0 | 6 |
| # | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 19.71 | 45.87 | 59.54 | 50.83 | 5.06 |
| CEPS(Rs) | 30.71 | 62.26 | 76.94 | 64.53 | 46.59 |
| DPS(Rs) | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Book NAV/Share(Rs) | 72.42 | 151.81 | 208.75 | 258.54 | 348.09 |
| Core EBITDA Margin(%) | 13.63 | 15.17 | 17.12 | 16.55 | 16.19 |
| EBIT Margin(%) | 13.1 | 13.81 | 15.81 | 15.19 | 10.08 |
| Pre Tax Margin(%) | 8.54 | 11.56 | 13.49 | 12.73 | 1.33 |
| PAT Margin (%) | 5.98 | 8.53 | 10.11 | 9.61 | 0.9 |
| Cash Profit Margin (%) | 9.31 | 11.58 | 13.06 | 12.2 | 8.3 |
| ROA(%) | 7.04 | 13.27 | 11.74 | 6.88 | 0.58 |
| ROE(%) | 27.21 | 41.5 | 33.03 | 21.75 | 1.71 |
| ROCE(%) | 19.67 | 28.75 | 23.47 | 13.01 | 7.41 |
| Receivable days | 72.61 | 60.23 | 63.47 | 67.46 | 68.51 |
| Inventory Days | 81.41 | 63.98 | 82.14 | 91.62 | 107.67 |
| Payable days | 71.62 | 73.95 | 71.85 | 47.79 | 52.82 |
| PER(x) | 17.34 | 41.9 | 25.2 | 31.75 | 338.83 |
| Price/Book(x) | 4.72 | 12.66 | 7.19 | 6.24 | 4.93 |
| Dividend Yield(%) | 0.15 | 0.03 | 0.03 | 0.03 | 0.03 |
| EV/Net Sales(x) | 1.44 | 3.84 | 3 | 4.02 | 3.9 |
| EV/Core EBITDA(x) | 8.77 | 22.77 | 15.98 | 22.25 | 22.05 |
| Net Sales Growth(%) | 0 | 70.45 | 9.61 | -11.61 | 12.62 |
| EBIT Growth(%) | 0 | 79.68 | 25.49 | -13.74 | -25.52 |
| PAT Growth(%) | 0 | 143.45 | 29.8 | -14.63 | -89.46 |
| EPS Growth(%) | 0 | 132.77 | 29.8 | -14.63 | -90.04 |
| Debt/Equity(x) | 2.03 | 1.02 | 1.33 | 1.89 | 1.35 |
| Current Ratio(x) | 1.12 | 1.29 | 1.38 | 1.07 | 1.39 |
| Quick Ratio(x) | 0.61 | 0.72 | 0.69 | 0.62 | 0.57 |
| Interest Cover(x) | 2.87 | 6.14 | 6.82 | 6.16 | 1.15 |
| Total Debt/Mcap(x) | 0.43 | 0.08 | 0.19 | 0.3 | 0.27 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 71.54 | 72.33 | 71.92 | 71.92 | 71.92 | 71.92 | 67.99 | 67.99 | 67.99 | 67.99 |
| FII | 0.13 | 0.13 | 1.05 | 0.97 | 0.99 | 1.41 | 7.24 | 6.99 | 6.9 | 7 |
| DII | 0 | 0 | 0 | 0 | 0.09 | 0.28 | 0.51 | 0.94 | 0.96 | 1.05 |
| Public | 28.33 | 27.54 | 27.03 | 27.11 | 26.99 | 26.38 | 24.25 | 24.08 | 24.15 | 23.96 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 | 0.82 |
| FII | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.02 | 0.09 | 0.08 | 0.08 | 0.08 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 0.32 | 0.31 | 0.31 | 0.31 | 0.31 | 0.3 | 0.29 | 0.29 | 0.29 | 0.29 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.14 | 1.14 | 1.14 | 1.14 | 1.14 | 1.14 | 1.21 | 1.21 | 1.21 | 1.21 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
